lt p gt Orexo is a specialty pharma company with commercial operations in the United States and R amp amp D in Sweden developing improved treatments using proprietary drug delivery technology. The company s product, Zubsolv buprenorphine and naloxone , for maintenance launched in the United States in September . lt /p gt
Quote | Orexo Ab Sp/Adr (OTCMKTS:ORXOY)
Last: | $1.37 |
---|---|
Change Percent: | 0.0% |
Open: | $0 |
Close: | $1.37 |
High: | $0 |
Low: | $0 |
Volume: | 72 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Orexo Ab Sp/Adr (OTCMKTS:ORXOY)
Orexo publishes the Annual and Sustainability Report for 2023 PR Newswire UPPSALA, Sweden , March 28, 2024 /PRNewswire/ -- Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com . The Swedish version o...
Correction: Notice of Annual General Meeting of Orexo PR Newswire The correction concerns the proposal regarding the number of board members as stated in the Swedish language version of the notice, which shall be five with no deputy members. UPPSALA, Sweden , ...
Message Board Posts | Orexo Ab Sp/Adr (OTCMKTS:ORXOY)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Orexo Ab Sp/Adr Company Name:
ORXOY Stock Symbol:
OTCMKTS Market:
Orexo publishes the Annual and Sustainability Report for 2023 PR Newswire UPPSALA, Sweden , March 28, 2024 /PRNewswire/ -- Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com . The Swedish version o...
Correction: Notice of Annual General Meeting of Orexo PR Newswire The correction concerns the proposal regarding the number of board members as stated in the Swedish language version of the notice, which shall be five with no deputy members. UPPSALA, Sweden , ...
Orexo successfully issues senior secured callable floating rate social bonds of SEK 500 m and announces results of the tender offer for its existing bonds PR Newswire UPPSALA, Sweden , March 13, 2024 /PRNewswire/ -- Orexo AB (publ), (" Orexo " or the " ...